WuXi Biologics revenue
WuXi Biologics (2269) reported revenue of $3.26 B for fiscal year 2025, +16.7% compared with the year before. Over the last 12 months revenue was $3.53 B.
Revenue 2025$3.26 B
Change+16.7%
World rank#709
Market cap$23.01 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $3.26 B | +16.7% |
| 2024 | $2.79 B | +9.63% |
| 2023 | $2.55 B | +11.6% |
| 2022 | $2.28 B | — |
Converted to US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.